Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melina Verso

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Data in Brief|August 3, 2019
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillationMichela Giustozzi, Maria Cristina Vedovati, Melina Verso, et al.
Internal and Emergency Medicine|March 5, 2008
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patientsMelina Verso, Giancarlo Agnelli, Pieter W Kamphuisen, et al.
Journal of Translational Medicine|October 22, 2011
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT studySandro Barni, Roberto Labianca, Giancarlo Agnelli, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio studyMelina Verso, Giancarlo Agnelli, Andrés Munoz, et al.
European Journal of Internal Medicine|July 11, 2016
Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-lifeMichela Giustozzi, Maria Cristina Vedovati, Paolo Verdecchia, et al.
International Journal of Cardiology|August 6, 2018
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort studyMaria Cristina Vedovati, Michela Giustozzi, Paolo Verdecchia, et al.
Thrombosis Research|October 4, 2011
Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1)Sergio Siragusa, Ugo Armani, Monica Carpenedo, et al.
Internal and Emergency Medicine|August 15, 2013
A prospective study on survival in cancer patients with and without venous thromboembolismGiancarlo Agnelli, Melina Verso, Mario Mandalà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patientsMelina Verso, Giancarlo Agnelli, Sergio Bertoglio, et al.
Internal and Emergency Medicine|June 28, 2024
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experienceRosa Talerico, Elisa Brando, Lorenzo Luzi, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Data in Brief|August 3, 2019
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillationMichela Giustozzi, Maria Cristina Vedovati, Melina Verso, et al.
Internal and Emergency Medicine|March 5, 2008
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patientsMelina Verso, Giancarlo Agnelli, Pieter W Kamphuisen, et al.
Journal of Translational Medicine|October 22, 2011
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT studySandro Barni, Roberto Labianca, Giancarlo Agnelli, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio studyMelina Verso, Giancarlo Agnelli, Andrés Munoz, et al.
European Journal of Internal Medicine|July 11, 2016
Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-lifeMichela Giustozzi, Maria Cristina Vedovati, Paolo Verdecchia, et al.
International Journal of Cardiology|August 6, 2018
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort studyMaria Cristina Vedovati, Michela Giustozzi, Paolo Verdecchia, et al.
Thrombosis Research|October 4, 2011
Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1)Sergio Siragusa, Ugo Armani, Monica Carpenedo, et al.
Internal and Emergency Medicine|August 15, 2013
A prospective study on survival in cancer patients with and without venous thromboembolismGiancarlo Agnelli, Melina Verso, Mario Mandalà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patientsMelina Verso, Giancarlo Agnelli, Sergio Bertoglio, et al.
Internal and Emergency Medicine|June 28, 2024
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experienceRosa Talerico, Elisa Brando, Lorenzo Luzi, et al.
Pageof 5